Medical comms - Press Releases

Date	Title	Company
15-Dec-2020	Biophytis Presents SARA-OBS study results at the Annual Conference of The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)	Biophytis
15-Dec-2020	The number of Russians ready to be vaccinated against coronavirus has reached 42%, a FOM poll shows	Russian Direct Investment Fund (RDIF)
15-Dec-2020	COVID-19 has made little positive impact on public perceptions of pharma, report suggests	Takeda UK
15-Dec-2020	Janssen Receives Positive CHMP Opinion for SPRAVATO®▼ (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder	Janssen Pharmaceutical Companies of Johnson & Johnson
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization	Carterra, Inc
15-Dec-2020	True Medical Partners with Trulioo to Provide Real-Time Identity Verification During Digital Onboarding and Meet Regulatory Compliance	Trulioo
15-Dec-2020	MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials	MinervaX
15-Dec-2020	Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer	AstraZeneca
15-Dec-2020	Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™	Acacia Pharma
15-Dec-2020	Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030	Sanofi
15-Dec-2020	Medovate announces new agreement with Mercury Medical® securing 100% distributor coverage for SAFIRA™ in the USA	Medovate
14-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
14-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
14-Dec-2020	TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy	SAREUM HOLDINGS PLC
14-Dec-2020	Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO	Ergomed plc
14-Dec-2020	ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available	ViiV Healthcare
14-Dec-2020	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	Moberg Pharma
14-Dec-2020	HBC and Tenet Partners initiate a long-term collaboration to build a global brand and launch HBC’s own branded consumer health products	Hofseth BioCare ASA
14-Dec-2020	Atox Bio announces FDA acceptance of New Drug Application	Arix Bioscience plc